Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial.

Autor: Muñoz-Rivas, Nuria^1,2 (AUTHOR) nmunozr@salud.madrid.org, Aibar, Jesús^3,4 (AUTHOR), Gabara-Xancó, Cristina^3,4 (AUTHOR), Trueba-Vicente, Ángela⁵ (AUTHOR), Urbelz-Pérez, Ana⁵ (AUTHOR), Gómez-Del Olmo, Vicente⁶ (AUTHOR), Demelo-Rodríguez, Pablo⁷ (AUTHOR), Rivera-Gallego, Alberto⁸ (AUTHOR), Bosch-Nicolau, Pau⁹ (AUTHOR), Perez-Pinar, Montserrat¹⁰ (AUTHOR), Rios-Prego, Mónica¹¹ (AUTHOR), Madridano-Cobo, Olga¹² (AUTHOR), Ramos-Alonso, Laura¹³ (AUTHOR), Alonso-Carrillo, Jesús¹⁴ (AUTHOR), Francisco-Albelsa, Iria¹⁵ (AUTHOR), Martí-Saez, Edelmira¹⁶ (AUTHOR), Maestre-Peiró, Ana¹⁷ (AUTHOR), Méndez-Bailón, Manuel^2,18 (AUTHOR), Hernández-Rivas, José Ángel^2,19 (AUTHOR) nmunozr@salud.madrid.org, Torres-Macho, Juan^1,2 (AUTHOR)

Publikováno v: Journal of Clinical Medicine. Oct2022, Vol. 11 Issue 19, p5632. 18p.